Studying features of MRKH syndrome
Part of Women’s health & pregnancy clinical trials.
This trial looks at the clinical and imaging details of MRKH syndrome, a condition present from birth affecting the uterus and vagina. It aims to improve understanding and care for those with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be female and have been diagnosed or suspected to have MRKH syndrome.
- You need to have a 46,XX chromosome pattern (typical female pattern).
- You must be between 10 and 60 years old.
- If you are joining the study for the first time, you (or a parent or guardian) must sign a consent form.
- If your data is already available from past care, it must have been collected following privacy rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at DNA (your genes) to better understand Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. It may help researchers learn more about the condition, and it can include both people with MRKH and healthy family relatives.
This study tests whether transplanting a uterus from a living related donor can be done safely and can help patients with MRKH type I achieve pregnancy. It also checks risks and safety issues for both the donor and recipient.
This trial tests a new gel-like material to create a vagina in women with MRKH syndrome, avoiding the need for surgery. It may offer a simpler, less invasive option.
This trial tests whether receiving a uterus transplant can allow someone with uterine absence to carry a pregnancy. It also looks at whether the procedure is safe for the patient and supports a future baby using frozen embryos.
This trial studies uterus transplant surgery to help people with “absolute uterine factor infertility” (no working uterus) become pregnant using embryos made by IVF. It checks whether the donated uterus can support pregnancy and safe delivery for participants who meet strict medical and health requirements.
This study looks at DNA changes to understand the cause of premature ovarian insufficiency (early menopause). It may help clarify what’s happening in your body and guide future care.
Hear when a new Mayer Rokitansky Kuster Hauser Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.